US2697961082

Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan

March 21, 2025 16:30 ET  | Source: Eagle Pharmaceuticals, Inc. WOODCLIFF LAKE, N.J., March 21, 2025 (GLOBE NEWSWIRE) -- Eagle…

2 weeks ago

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration

November 15, 2024 17:00 ET | Source: Eagle Pharmaceuticals, Inc. WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Eagle…

5 months ago